Further developments include VEGFR1- and VEGFR2-specific imaging probes, 89Zr-labeled scVR1/Zr and scVR2/Zr, respectively, which allow selective imaging of VEGFR1+ and VEGFR2+ cells at different stages of cancer progression [119]. This evidence concerns the gene KDR and cancer.